Owner Scorecard


← All companies ← ALK Manual ALKT → ← AKBA Pharmaceuticals ALMS →

ALKS, Alkermes

Pharmaceuticals consumer brand Distress / turnaround

A pharmaceutical business, where patents grant a temporary monopoly the pipeline must keep refilling.

Latest annual: FY2025 10-K
ALKS · Alkermes
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$1.5B
−5.2% YoY · 7% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $1.7B 5-yr avg $1.4B
Gross margin 85% 5-yr avg 84%
Operating margin 7.0% 5-yr avg 15.4%
ROIC 3% 5-yr avg 15%
Owner-earnings margin 13% 5-yr avg 17%
Free cash flow margin 13% 5-yr avg 17%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Distress / turnaround. Thin interest coverage, or operating cash burned against real debt, across the record. The balance sheet carries this situation; the debt schedule sets the clock.
What moves the needle
Operating margin has reached 27% at its best but run negative through the cycle (median −4.8%) on a 84% gross margin — so the question is which reading is truer: whether the median was pulled below zero by one-off charges, by the cycle, or by spending it is still growing into, and whether it settles back at a profit. Stock-based pay runs about 8.5% of sales, a real and recurring claim on owners that the GAAP margin understates. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median −7%, above 15% in 1 of 8 years). By owner earnings: roughly 3% of revenue reaches owners as cash, though it swings. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMJun 2026
Income statement
$746M$903M$1.1B$1.2B$1.0B$1.2B$1.1B$1.7B$1.6B$1.5B$1.7BRevenueRevenue
$614M$749M$918M$991M$860M$976M$894M$1.4B$1.3B$1.3B$1.4BGross profitGross prof.
82%83%84%85%83%83%80%85%84%87%85%Gross marginGross mgn
50%47%48%51%52%47%53%41%41%48%50%SG&A / revenueSG&A/rev
52%46%39%44%38%25%25%16%16%22%23%R&D / revenueR&D/rev
($209M)($148M)($99M)($175M)($112M)$98M($6M)$414M$421M$254M$117MOperating incomeOp. inc.
−28.0%−16.4%−9.1%−15.0%−10.8%8.3%−0.5%24.9%27.0%17.2%7.0%Operating marginOp. mgn
($214M)($143M)($127M)($197M)($97M)$88M($31M)$422M$444M$291MPretax incomePretax
($208M)($158M)($139M)($197M)($111M)($48M)($158M)$356M$367M$242M$66MNet incomeNet inc.
13%16%17%32%Effective tax rateTax rate
Cash flow & returns
($64M)$19M$99M$72M$83M$102M$21M$401M$439M$521M$251MOperating cash flowOp. cash
$94M$99M$104M$80M$82M$79M$78M$75M$29M$27M$62MDepreciationDeprec.
($44M)($5M)$30M$87M$22M($16M)$7M($130M)($53M)$153M$5MWorking capital & otherWC & other
$44M$51M$69M$91M$42M$28M$38M$48M$33M$40M$30MCapexCapex
5.9%5.7%6.3%7.8%4.1%2.4%3.4%2.9%2.1%2.7%1.8%Capex / revenueCapex/rev
($107M)($32M)$30M($19M)$41M$74M($17M)$353M$406M$494M$222MOwner earningsOwner earn.
−14.4%−3.6%2.7%−1.6%3.9%6.3%−1.5%21.2%26.0%33.4%13.3%Owner earnings marginOE mgn
($107M)($32M)$30M($19M)$41M$74M($17M)$353M$406M$480M$222MFree cash flowFCF
−14.4%−3.6%2.7%−1.6%3.9%6.3%−1.5%21.2%26.0%32.5%13.3%Free cash flow marginFCF mgn
$127M($18M)($22M)($142M)($11M)($66M)($65M)$53M($111M)$295MInvesting cash flowInv. cash
($58M)$4M($2M)$7M($2M)$29M($2M)($290M)($494M)$12MFinancing cash flowFin. cash
$5M$5M$75M($63M)$69M$65M($45M)$165M($166M)$829MChange in cashΔ cash
-13%-9%-7%-12%-8%-0%30%15%3%ROICROIC
-17%-13%-12%-18%-10%-4%-15%30%25%13%4%Return on equityROE
−17%−13%−12%−18%−10%−4%−15%30%25%13%4%Retained to equityRetained/eq
Balance sheet
$308M$349M$539M$535M$635M$536M$292M$457M$291M$389M$848MCash & investmentsCash+inv
$191M$234M$292M$257M$275M$313M$288M$332M$385M$334M$456MReceivablesReceiv.
$63M$93M$90M$102M$126M$150M$181M$186M$183M$197M$299MInventoryInvent.
$46M$56M$40M$54M$46M$56M$33M$66M$46M$108M$143MAccounts payablePayables
$208M$271M$343M$305M$355M$408M$437M$453M$522M$423M$613MOperating working capitalOper. WC
$791M$809M$983M$962M$1.1B$1.1B$1.1B$1.5B$1.4B$1.9B$1.5BCurrent assetsCur. assets
$212M$291M$340M$391M$438M$471M$498M$520M$465M$543M$662MCurrent liabilitiesCur. liab.
3.7×2.8×2.9×2.5×2.5×2.3×2.3×2.9×3.0×3.5×2.3×Current ratioCurr. ratio
$265M$285M$310M$362M$350M$341M$223M$227M$228M$222MNet PP&ENet PP&E
$93M$93M$93M$93M$93M$93M$83M$83M$83M$83M$594MGoodwillGoodwill
$1.7B$1.8B$1.8B$1.8B$1.9B$2.0B$2.0B$2.1B$2.1B$2.5B$4.4BTotal assetsAssets
$284M$281M$279M$277M$275M$296M$293M$291M$1.5BTotal debtDebt
($25M)($67M)($260M)($258M)($360M)($241M)$797K($167M)$655MNet debt / (cash)Net debt
-14.0×-12.3×-6.4×-12.9×-13.0×8.7×-0.5×18.0×18.6×20.7×2.0×Interest coverageInt. cov.
$517M$594M$654M$720M$883M$912M$920M$934M$591M$668MTotal liabilitiesTotal liab.
$1.2B$1.2B$1.2B$1.1B$1.1B$1.1B$1.0B$1.2B$1.5B$1.8B$1.8BShareholders’ equityEquity
12.7%9.3%9.6%8.6%8.7%7.5%8.5%6.1%6.2%6.7%7.1%Stock comp / revenueSBC/rev
Per share
151M153M155M157M159M165M164M170M169M169M167MShares out (diluted)Shares
$4.92$5.89$7.05$7.46$6.54$7.12$6.79$9.80$9.21$8.75$10.01Revenue / shareRev/sh
$-1.38$-1.03$-0.90$-1.25$-0.70$-0.29$-0.97$2.10$2.17$1.43$0.40EPS (diluted)EPS
$-0.71$-0.21$0.19$-0.12$0.26$0.45$-0.11$2.08$2.40$2.93$1.33Owner earnings / shareOE/sh
$-0.71$-0.21$0.19$-0.12$0.26$0.45$-0.11$2.08$2.40$2.85$1.33Free cash flow / shareFCF/sh
$0.29$0.33$0.45$0.58$0.27$0.17$0.23$0.28$0.20$0.24$0.18Cap. spending / shareCapex/sh
$7.98$7.84$7.55$6.91$6.72$6.75$6.37$7.09$8.66$10.78$10.85Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+6.6%/yr+6.0%/yr
Owner earnings / share+62.8%/yr
Capital spending / share−2.0%/yr−2.1%/yr
Book value / share+3.4%/yr+9.9%/yr

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2017FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business earned $494M of owner earnings, the operating cash left after the $27M it takes just to hold its position. It put $13M more into growth; free cash flow, after that spending, was $480M.

Reported net income$242M
Owner earnings$494M · 33% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$242M$367M$356M($158M)($48M)
Depreciation & amortizationnon-cash charge added back+$27M+$29M+$75M+$78M+$79M
Stock-based compensationreal costnon-cash, but a real cost+$99M+$97M+$101M+$94M+$88M
Working capital & othertiming of cash in and out, other non-cash items+$153M−$53M−$130M+$7M−$16M
Cash from operations$521M$439M$401M$21M$102M
Maintenance capital expenditurethe spending needed just to hold position and volume−$27M−$33M−$48M−$38M−$28M
Owner earnings$494M$406M$353M($17M)$74M
Growth capital expenditurediscretionary; spent to get bigger, not to stand still−$13M
Free cash flow$480M$406M$353M($17M)$74M
Owner-earnings marginowner earnings ÷ revenue33%26%21%-2%6%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the maintenance capital it must spend to hold its position (here about $27M, roughly its depreciation, the rate its assets wear out). The other $13M of its capital spending is growth it chose, not upkeep it owed; charged only with the maintenance it must do, the business earns well more than the year's free cash flow shows. The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $99M), owner earnings is nearer $395M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Comfortable
    Operating income $254M ÷ interest expense $12M
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • Net cash
    Cash $389M − debt $291M
    What this means

    Cash and short-term investments exceed every dollar of debt by $98M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 83 + DIO 365 − DPO 201 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Below average through the cycle
    8-yr median, range -13%–30%; 12% latest = NOPAT $211M ÷ invested capital $1.7B
    Industry peers: median -25%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 8 years (it ran 12% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • High, recently turned positive
    latest $494M = operating cash $521M − maintenance capex $27M; positive each of the last 3 years, after an earlier loss stretch (10-yr median 3%)
    Industry peers: median -2%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 33% of revenue this year, a 3% median across 10 years. Treating stock comp as the real expense it is (less $99M of SBC) leaves $395M.

  • Cash-backed
    Cash from ops $521M ÷ net income $242M
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 1.49×
    Expanding
    Capex $40M ÷ depreciation $27M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Heavy selling cost
    Selling and marketing $480M ÷ revenue $1.5B
    What this means

    Sales and marketing as a share of revenue, kept apart from administrative overhead because it answers a different question: how much a business must spend to win the next customer. A company whose product pulls customers in spends little here and keeps the difference; one that must buy its growth is running to stand still, and the spending has to keep rising for revenue to keep rising. Read it beside the growth rate, not alone.

  • Is the buyback buying ownership, or mopping up? 6.7%
    The count is rising
    Stock compensation $99M (fiscal 2025), 6.7% of revenue · no repurchases · diluted shares +3.1% since 2022
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 2 of 4 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Near
    Revenue ≥ $2B · $1.5B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 3.55×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $291M vs $1.4B WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (10-yr record) · 7 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record
    Uninterrupted dividends · no dividend line tagged in the data
    What this means

    An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.

  • Earnings growth
    Earnings +33% over the record ·
    What this means

    Earnings were negative early in the record, a growth rate isn't meaningful.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $1.92/share (latest year $1.44), the averaged base the calculator's gate runs on, and book value is $10.84/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 3 of 10
    What this means

    Lost money in 7 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 1 of 8 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin −18% → 23% (3-yr avg ends)

    In the filing’s words The filing ties gains to its own pricing, but names price competition too — pricing power that is real yet contested, not unopposed. The margin shows who is winning.

    What this means

    Through the cycle the operating margin widened — about −18% early to 23% lately, median −9% — pricing power intact or improving.

  • Reinvestment, incremental ROIC returns capital
    What this means

    The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.

  • Worst year 2016 · −28.0% op. margin
    What this means

    Operations went underwater in 2016, understand why before trusting the good years.

  • Share count +1.2%/yr
    What this means

    The share count is rising, dilution works against you on a per-share basis.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Jun 30, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$1.5B
  • Cash & short-term investments$710M
  • Receivables$456M
  • Inventory$299M
  • Other current assets$57M
Current liabilities$662M
  • Debt due within a year$27M
  • Accounts payable$143M
  • Other current liabilities$493M
Current ratio2.30×all current assets ÷ what's due · Graham looked for 2×
Quick ratio1.85×stricter: inventory excluded
Cash ratio1.07×strictest: cash alone against what's due
Working capital$861Mthe cushion left after near-term bills
Debt due this year vs. cash$27M due · $710M cash covered by cash on hand, no refinancing forced · both figures from the Jun 30, 2026 balance sheet
Revenue, latest quarter vs. a year ago+27.0%the freshest read on whether the business is still growing
Current ratio, recent quarters3.4× → 2.3×
Deeper floors
Tangible book value($547M)equity stripped of goodwill & intangibles
Net current asset value($1.1B)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$1.6B$69M of it operating leases
Deferred revenue$11Mcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $1.7B of operating cash; how management split it reads as a cash builder, a large share of cash simply built up on the balance sheet.

  • Reinvested$486M · 29%
  • Buybacks$200M · 12%
  • Retained (debt / cash)$1.0B · 59%
  • Returned to owners$200M

    16% of the owner earnings the business produced over the span, $0 as dividends and $200M as buybacks.

  • Source of fundingOperating cash

    Operating cash covered reinvestment and returns; over the span debt rose $1.2B and cash and short-term investments rose $524M.

  • Average price paid for buybacks$25.35

    Across the years where the filing reports a share count, 8M shares were bought for $200M, about $25.35 each.

  • Net change in share count10.0%

    The diluted count rose from 151M to 167M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.

  • Dividend record

    No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2021Richard F. Pops$8.8M$11.2M$74M
2022Richard F. Pops$10.3M$8.3M($17M)
2023Richard F. Pops$9.4M$9.0M$353M
2024Richard F. Pops$10.1M$14.6M$406M
2025Richard F. Pops$7.9M$12.6M$494M

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership4.6%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • CEO pay ratio30:1

    What the chief earns for every dollar the median employee makes, per the 2026 proxy. A high ratio alone settles nothing; some businesses are genuinely top-heavy in scarce skill. A runaway figure is where Buffett starts asking whether the board is doing its job.

  • Stock-based compensation$99M

    The slice of the business handed to employees in shares in fiscal 2025, 6.7% of revenue, equal to 38.9% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition, Income taxes as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Pharmaceuticals

The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
PTCTPTC Therapeutics Inc.$1.7B96%3y-55.4%-45%-28%
ALKSAlkermes$1.5B84%-4.8%-7%3%
PAHCPhibro Animal Health Corporation$1.3B32%8.8%16%3%
LKFTLakefront Biotherapeutics$1.3B92%2y-37.1%-6%-106%
INDVIndivior Pharmaceuticals Inc.$1.2B82%-2.9%-2%
ENLVEnlivex Ltd.$1.2B-1.2%1y-62%-1%1y
PBHPrestige Consumer Healthcare$1.1B56%29.0%8%21%
ACADACADIA Pharmaceuticals Inc.$1.1B94%-43.2%-48%-26%
Group median84%-3.8%-7%-1%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Alkermes has delivered.

Alkermes’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.

$

Through the cycle, Alkermes earns about $49M on its 3.3% median owner-earnings margin. This year’s 33.4% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.

Base

The assumptions

9.0% = the 4.68% 10-year Treasury (Jul 30, 2026) + 4.32 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25+100%/yr
Owner-earnings growth · since FY2023+17%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.68%, as of Jul 30, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $222M on 168M shares outstanding, per the 10-Q cover, as of 2026-07-23; net debt $793M. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Alkermes (ALKS), the owner's record," https://ownerscorecard.com/c/ALKS, data as of 2026-07-18.

Manual order: ← ALK its page in the Manual ALKT →

Industry order: ← AKBA the Pharmaceuticals chapter ALMS →